Dependence of transient and residual calcium dynamics on action-potential patterning during neuropeptide secretion.
Secretion of the neuropeptide arginine vasopressin (AVP) from the neurohypophysis is optimized by short phasic bursts of action potentials with a mean intraburst frequency around 10 Hz. Several hypotheses, most prominently action-potential broadening and buildup of residual calcium, have been proposed to explain this frequency dependence of AVP release. However, how either of these mechanisms would optimize release at any given frequency remains an open question. We have addressed this issue by correlating the frequency-dependence of intraterminal calcium dynamics and AVP release during action-potential stimulation. By monitoring the intraterminal calcium changes with low-affinity indicator dyes and millisecond time resolution, the signal could be dissected into three separate components: rapid Ca(2+) rises (Delta[Ca(2+)](tr)) related to action-potential depolarization, Ca(2+) extrusion and/or uptake, and a gradual increase in residual calcium (Delta[Ca(2+)](res)) throughout the stimulus train. Action-potential stimulation modulated all three components in a manner dependent on both the stimulation frequency and number of stimuli. Overall, the cumulative Delta[Ca(2+)](tr) amplitude initially increased with f(Stim) and then rapidly deteriorated, with a maximum around f(Stim) </= 5 Hz. Residual calcium levels, in contrast, increased monotonically with stimulation frequency. Simultaneously with the calcium measurements we determined the amount of AVP release evoked by each stimulus train. Hormone release increased with f(Stim) beyond the peak in Delta[Ca(2+)](tr) amplitudes, reaching its maximum between 5 and 10 Hz before returning to its 1 Hz level. Thus, AVP release responds to the temporal patterning of stimulation, is sensitive to both Delta[Ca(2+)](tr) and Delta[Ca(2+)](res), and is optimized at a frequency intermediate between the frequency-dependent maxima in Delta[Ca(2+)](tr) and Delta[Ca(2+)](res).
Muschol
M
M
Departments of Neuroscience and Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6074, USA.
Salzberg
B M
BM
D000200:Action Potentials / Q000502:physiology*; D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism; D002118:Calcium / Q000378:metabolism* / Q000493:pharmacokinetics; D004558:Electric Stimulation; D005260:Female; D066298:In Vitro Techniques; D051379:Mice; D009479:Neuropeptides / Q000378:metabolism*; D010904:Pituitary Gland, Posterior / Q000378:metabolism*; D017729:Presynaptic Terminals / Q000378:metabolism; D011930:Reaction Time
D009479:Neuropeptides; D001127:Arginine Vasopressin; D002118:Calcium